Suppr超能文献

羊毛硫抗生素植物乳杆菌素C基于脂质II的抗菌活性。

Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.

作者信息

Wiedemann Imke, Böttiger Tim, Bonelli Raquel Regina, Schneider Tanja, Sahl Hans-Georg, Martínez Beatriz

机构信息

Institut für Medizinische Mikrobiologie une Immunologie-Pharmazeutische Mikrobiologie, Universität Bonn, D-53115 Bonn, Germany.

出版信息

Appl Environ Microbiol. 2006 Apr;72(4):2809-14. doi: 10.1128/AEM.72.4.2809-2814.2006.

Abstract

We analyzed the mode of action of the lantibiotic plantaricin C (PlnC), produced by Lactobacillus plantarum LL441. Compared to the well-characterized type A lantibiotic nisin and type B lantibiotic mersacidin, which are both able to interact with the cell wall precursor lipid II, PlnC displays structural features of both prototypes. In this regard, we found that lipid II plays a key role in the antimicrobial activity of PlnC besides that of pore formation. The pore forming activity of PlnC in whole cells was prevented by shielding lipid II on the cell surface. However, in contrast to nisin, PlnC was not able to permeabilize Lactococcus lactis cells or to form pores in 1,2-dioleoyl-sn-glycero-3-phosphocholine liposomes supplemented with 0.1 mol% purified lipid II. This emphasized the different requirements of these lantibiotics for pore formation. Using cell wall synthesis assays, we identified PlnC as a potent inhibitor of (i) lipid II synthesis and (ii) the FemX reaction, i.e., the addition of the first Gly to the pentapeptide side chain of lipid II. As revealed by thin-layer chromatography, both reactions were clearly blocked by the formation of a PlnC-lipid I and/or PlnC-lipid II complex. On the basis of the in vivo and in vitro activities of PlnC shown in this study and the structural lipid II binding motifs described for other lantibiotics, the specific interaction of PlnC with lipid II is discussed.

摘要

我们分析了植物乳杆菌LL441产生的羊毛硫抗生素植物乳杆菌素C(PlnC)的作用模式。与已被充分表征的A型羊毛硫抗生素乳酸链球菌素和B型羊毛硫抗生素短杆菌肽相比,它们都能够与细胞壁前体脂质II相互作用,而PlnC兼具这两种原型的结构特征。在这方面,我们发现脂质II除了在形成孔道方面发挥作用外,在PlnC的抗菌活性中也起着关键作用。通过屏蔽细胞表面的脂质II,可防止PlnC在全细胞中的成孔活性。然而,与乳酸链球菌素不同,PlnC无法使乳酸乳球菌细胞通透,也无法在补充了0.1 mol%纯化脂质II的1,2 - 二油酰 - sn - 甘油 - 3 - 磷酸胆碱脂质体中形成孔道。这强调了这些羊毛硫抗生素在形成孔道方面的不同要求。通过细胞壁合成试验,我们确定PlnC是(i)脂质II合成和(ii)FemX反应(即向脂质II的五肽侧链添加第一个甘氨酸)的有效抑制剂。如薄层色谱所示,这两个反应均因形成PlnC - 脂质I和/或PlnC - 脂质II复合物而被明显阻断。基于本研究中显示的PlnC的体内和体外活性以及针对其他羊毛硫抗生素描述的与脂质II结合的结构基序,讨论了PlnC与脂质II的特异性相互作用。

相似文献

1
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Appl Environ Microbiol. 2006 Apr;72(4):2809-14. doi: 10.1128/AEM.72.4.2809-2814.2006.
2
Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Microb Drug Resist. 2012 Jun;18(3):261-70. doi: 10.1089/mdr.2011.0242. Epub 2012 Mar 20.
4
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Science. 2006 Sep 15;313(5793):1636-7. doi: 10.1126/science.1129818.
5
Antimicrobial mechanism of lantibiotics.
Biochem Soc Trans. 2012 Dec 1;40(6):1528-33. doi: 10.1042/BST20120190.
7
Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
J Am Chem Soc. 2012 Feb 29;134(8):3687-90. doi: 10.1021/ja300007h. Epub 2012 Feb 17.
8
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57. doi: 10.1128/AAC.50.4.1449-1457.2006.
9
Elucidation of the antimicrobial mechanism of mutacin 1140.
Biochemistry. 2008 Mar 11;47(10):3308-14. doi: 10.1021/bi701262z. Epub 2008 Feb 12.
10
New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
Biochemistry. 2016 Jan 12;55(1):232-7. doi: 10.1021/acs.biochem.5b01173. Epub 2015 Dec 22.

引用本文的文献

1
Mixed Culture Cultivation in Microbial Bioprocesses.
Adv Biochem Eng Biotechnol. 2025;189:9-69. doi: 10.1007/10_2023_248.
2
Lactic acid bacteria as an eco-friendly approach in plant production: Current state and prospects.
Folia Microbiol (Praha). 2024 Jun;69(3):465-489. doi: 10.1007/s12223-024-01146-3. Epub 2024 Feb 23.
3
Chemical genetic approaches for the discovery of bacterial cell wall inhibitors.
RSC Med Chem. 2023 Aug 30;14(11):2125-2154. doi: 10.1039/d3md00143a. eCollection 2023 Nov 15.
4
Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.
Chem Rev. 2022 Sep 28;122(18):14722-14814. doi: 10.1021/acs.chemrev.2c00210. Epub 2022 Sep 1.
6
A Novel Bacteriocin From ZFM94 and Its Antibacterial Mode of Action.
Front Nutr. 2021 Jul 23;8:710862. doi: 10.3389/fnut.2021.710862. eCollection 2021.
7
Perspectives on Probiotics and Bronchopulmonary Dysplasia.
Front Pediatr. 2020 Oct 23;8:570247. doi: 10.3389/fped.2020.570247. eCollection 2020.
8
Cell wall homeostasis in lactic acid bacteria: threats and defences.
FEMS Microbiol Rev. 2020 Sep 1;44(5):538-564. doi: 10.1093/femsre/fuaa021.
9
In Vitro Antimicrobial Activity and Probiotic Potential of and against Species of .
Nutrients. 2019 Feb 21;11(2):448. doi: 10.3390/nu11020448.
10
Genome Analysis of LL441 and Genetic Characterisation of the Locus for the Lantibiotic Plantaricin C.
Front Microbiol. 2018 Aug 17;9:1916. doi: 10.3389/fmicb.2018.01916. eCollection 2018.

本文引用的文献

1
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57. doi: 10.1128/AAC.50.4.1449-1457.2006.
2
Bactericidal mode of action of plantaricin C.
Appl Environ Microbiol. 1996 Aug;62(8):2701-9. doi: 10.1128/aem.62.8.2701-2709.1996.
3
Bacterial lantibiotics: strategies to improve therapeutic potential.
Curr Protein Pept Sci. 2005 Feb;6(1):61-75. doi: 10.2174/1389203053027584.
4
Post-translational modifications during lantibiotic biosynthesis.
Curr Opin Chem Biol. 2004 Oct;8(5):498-507. doi: 10.1016/j.cbpa.2004.08.005.
5
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.
Nat Struct Mol Biol. 2004 Oct;11(10):963-7. doi: 10.1038/nsmb830. Epub 2004 Sep 12.
7
Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.
J Bacteriol. 2004 May;186(10):3259-61. doi: 10.1128/JB.186.10.3259-3261.2004.
8
Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.
Appl Environ Microbiol. 2003 Jul;69(7):3777-83. doi: 10.1128/AEM.69.7.3777-3783.2003.
10
Ribosomally synthesized antibacterial peptides in Gram positive bacteria.
Curr Drug Targets. 2002 Apr;3(2):107-22. doi: 10.2174/1389450024605409.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验